Complement-mediated T-cell depletion of bone marrow: comparison of T10B9.1A-31 and Muromonab-Orthoclone OKT3
Carolyn A. Keever-Taylor(Medical College of Wisconsin), B. Giesen(Medical College of Wisconsin), Pingfu Fu(Medical College of Wisconsin), Huilan Zeng(Chongqing University), ANN CRAIG(Medical College of Wisconsin), A. Loebel(Medical College of Wisconsin), Mary Molter(Medical College of Wisconsin), J.A. Skonecki(Medical College of Wisconsin)
Cited by 21
Related Papers
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
|New England Journal of Medicine|2018|584
Comparative Outcomes of Donor Graft CD34<sup>+</sup> Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation
|Journal of Clinical Oncology|2012|157
Enhancement of skin wound healing with decellularized scaffolds loaded with hyaluronic acid and epidermal growth factor
|Materials Science and Engineering C|2014|95
Identifying circRNA-associated-ceRNA networks in retinal neovascularization in mice
|International Journal of Medical Sciences|2019|73
The role of microglia in the progression of glaucomatous neurodegeneration- a review
|International Journal of Ophthalmology|2018|55